FDA Amends Notice for Joint Meeting of Drug Safety and Risk Management Advisory Committee and Anesthetic and Analgesic Drug Products Advisory Committee

Summary

The US Food and Drug Administration (FDA) is updating a notice for a joint meeting of its advisory committees, which was originally announced on January 11, 2017, to reflect a change in the meeting address.